Bioinspired platelet membrane-cloaked ROS-responsive nanozymes enable synergistic therapy of acute kidney injury via immunomodulation and ferroptosis suppression.
A platelet membrane-coated, reactive oxygen species (ROS)-responsive nanozyme (BAPCs@PM) for synergistic AKI therapy is reported, providing an innovative biomimetic and responsive therapeutic strategy by combining ultrasmall nanozymes, natural bioactive molecules, and biomimetic membrane engineering.